HB456 would create a new statutory framework in Hawaii allowing the direct sale and distribution of raw, unpasteurized milk and raw milk products from small-scale producers to consumers for human consumption, beginning July 1, 2026. The bill defines key terms such as raw milk, raw milk producer, raw milk dairy, raw milk product, and raw milk dairy product, and limits eligibility to dairies with no more than ten milk-bearing animals. It also allows raw goat milk to be sold for pet consumption under a separate set of rules.
The measure sets detailed operational requirements for producers, including annual veterinary exams, monthly testing for coliform and standard plate counts, recordkeeping for three years, temperature and time limits for storage and distribution, restrictions on redistribution, and mandatory warning labels on containers. It also requires the Board of Agriculture and the Department of Health to adopt implementing rules by July 1, 2026, covering sanitation, testing, storage, handling, transportation, and animal-sharing arrangements. The bill amends existing milk licensing and penalty provisions so that compliant direct raw milk sales would not violate current milk laws, effectively carving out an exception from the state’s general prohibition on unlicensed milk distribution.
In addition to human-consumption sales, HB456 authorizes the sale of raw goat milk for pet consumption, with labeling that warns it may contain bacteria harmful to humans. The bill is structured to preserve existing rights and liabilities before its effective date and would take effect on July 1, 2025, while the new raw milk sales regime would not begin until July 1, 2026. It is also titled the “Mark Nakashima Act.”
The bill’s impact on state law would be significant because Hawaii currently prohibits any form of raw milk distribution; HB456 would create a new legal pathway for direct-to-consumer raw milk sales and exempt those sales from the chapter’s misdemeanor penalties when done in compliance with the new part. It would also require new administrative rules from both the Board of Agriculture and the Department of Health, and it would add new labeling, testing, and enforcement provisions that affect producers, consumers, veterinarians, and regulators.
The available context suggests a generally favorable or at least permissive posture toward the bill’s purpose, as reflected in the bill findings emphasizing consumer choice, taste, and claimed health benefits, along with the report description stating that the bill authorizes and decriminalizes direct sales subject to restrictions. However, there is no recorded committee transcript or vote history in the provided materials, so no direct evidence of support or opposition from legislators is available. The main point of contention inherent in the bill is the public health risk of raw milk versus consumer freedom and market access: the bill acknowledges that raw milk may contain harmful bacteria, while supporters appear to favor regulated access and opponents would likely focus on food safety, inspection, and disease concerns.
HB456 would amend Hawaii Revised Statutes chapter 157 to create a new raw milk regulatory part and would modify existing licensing and penalty provisions so that compliant direct sales of raw milk, raw milk products, and raw milk dairy products are not treated as violations of the milk code. It would also add a new section to chapter 321 authorizing raw goat milk sales for pet consumption. The bill would require rulemaking by the Board of Agriculture and the Department of Health and would impose new producer obligations for testing, labeling, recordkeeping, storage, and distribution.
The bill’s stated purpose and report description indicate a generally supportive or pro-access sentiment, emphasizing consumer choice, direct farm sales, and regulated legalization rather than prohibition. At the same time, the bill itself includes prominent warning labels and safety controls, suggesting an effort to balance access with public health concerns. Because no committee transcripts or votes were provided, there is no documented floor or committee sentiment beyond the bill’s framing and formal description.
The central policy dispute is likely between advocates of raw milk access, who argue for consumer choice, local producer sales, and perceived health or taste benefits, and public health critics, who would be concerned about bacterial contamination, lack of pasteurization, and the risks of uninspected dairy products. The bill tries to address those concerns through small-herd limits, mandatory testing, veterinarian exams, temperature controls, and warning labels, but those safeguards may still be viewed as insufficient by opponents. Another likely point of contention is whether the Department of Health and Board of Agriculture should be tasked with creating a new regulatory regime for a product that is currently prohibited.